Atlas Trials

Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass

Clinical trial NCT00585013 · COMPLETED

Trial details

NCT number
NCT00585013
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Congenital Heart Disease
Start date
2008-01-01
Primary completion
2011-06-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.